MYD Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Myriad Genetics Inc

Watchlist Manager

Watchlist

Price: 5.842 EUR -0.44% Market Closed

Market Cap: €528.7m

M	Myriad Genetics Inc F:MYD	US
H	Henry Schein Inc XMUN:HS2	US
	Repay Holdings Corp F:0YR	US
	Siemens AG F:SIE	DE
S	Stantec Inc NYSE:STN	CA
	Primo Brands Corp F:V76	US
V	Vienna Insurance Group Wiener Versicherung Gruppe AG F:WSV2	AT
R	Recupero Etico Sostenibile SpA MIL:RES	IT

Profitability Summary

Myriad Genetics Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

69%

Strong 3Y Average Gross Margin

70%

Declining Gross Margin

69% > 69%

Negative Operating Margin

-11%

Negative 3Y Average Operating Margin

-12%

Operating Margin is Increasing

-22% > -11%

Negative Net Margin

-14%

Negative 3Y Average Net Margin

-30%

Net Margin is Increasing

-37% > -14%

Negative Free Cash Flow Margin

-2%

Negative 3Y Average Free Cash Flow Margin

-9%

Free Cash Flow Margin is Increasing

-19% > -2%

Negative ROE

-33%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-11%

Declining ROIC

-15% > -16%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

69%

Strong 3Y Average Gross Margin

70%

Declining Gross Margin

69% > 69%

Negative Operating Margin

-11%

Negative 3Y Average Operating Margin

-12%

Operating Margin is Increasing

-22% > -11%